PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 79 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 44.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $41,000 | -22.6% | 8,262 | -5.0% | 0.00% | – |
Q2 2019 | $53,000 | +32.5% | 8,700 | 0.0% | 0.00% | – |
Q1 2019 | $40,000 | +11.1% | 8,700 | 0.0% | 0.00% | – |
Q4 2018 | $36,000 | +1700.0% | 8,700 | +2330.2% | 0.00% | – |
Q1 2018 | $2,000 | 0.0% | 358 | 0.0% | 0.00% | – |
Q4 2017 | $2,000 | -99.4% | 358 | -98.9% | 0.00% | -100.0% |
Q2 2017 | $320,000 | 0.0% | 33,907 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $320,000 | +9.6% | 33,907 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $292,000 | -12.3% | 33,907 | -58.5% | 0.00% | -33.3% |
Q1 2014 | $333,000 | +82.0% | 81,662 | +136.9% | 0.00% | +50.0% |
Q4 2013 | $183,000 | +5.8% | 34,468 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $173,000 | +13.1% | 34,468 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $153,000 | +88.9% | 34,468 | +22.3% | 0.00% | -77.8% |
Q3 2012 | $81,000 | -80.0% | 28,179 | -32.0% | 0.01% | -59.1% |
Q1 2012 | $406,000 | +361.4% | 41,439 | +107.1% | 0.02% | +29.4% |
Q4 2009 | $88,000 | -21.4% | 20,008 | -6.9% | 0.02% | -26.1% |
Q3 2009 | $112,000 | +1.8% | 21,483 | 0.0% | 0.02% | -11.5% |
Q2 2009 | $110,000 | -22.0% | 21,483 | 0.0% | 0.03% | -35.0% |
Q1 2009 | $141,000 | -36.2% | 21,483 | 0.0% | 0.04% | -28.6% |
Q4 2008 | $221,000 | -22.5% | 21,483 | 0.0% | 0.06% | +1.8% |
Q3 2008 | $285,000 | -16.2% | 21,483 | 0.0% | 0.06% | -8.3% |
Q2 2008 | $340,000 | +217.8% | 21,483 | +30.7% | 0.06% | +275.0% |
Q1 2008 | $107,000 | – | 16,438 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
IFP Advisors, Inc | 0 | $0 | 0.00% |
NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |